高级检索
当前位置: 首页 > 详情页

Nanoparticle-conjugated aptamer targeting hnRNP A2/B1 can recognize multiple tumor cells and inhibit their proliferation

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ EI

机构: [1]Beijing Inst Basic Med Sci, Beijing 100850, Peoples R China [2]Acad Mil Med Sci, State Key Lab Toxicol & Med Countermeasures, Beijing 100850, Peoples R China [3]Acad Mil Med Sci, Lab Toxicant Anal, Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China [4]Wuhan Univ, Wuhan City Hosp 3, Deparment Orthoped, Wuhan 430060, Peoples R China [5]Wuhan Univ, Tongren Hosp, Wuhan 430060, Peoples R China [6]Beijing Inst Lab Blood Borne Virus, Beijing 100850, Peoples R China
出处:
ISSN:

关键词: Tumor cells SELEX Aptamer Heterogeneous nuclear ribonucleoprotein A2/B1 Nanoparticles

摘要:
In this study, we further investigated a previously developed aptamer targeting ROS 17/2.8 (rat osteosarcoma) cells. We found that this C6-8 aptamer specifically binds to heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 and that it specifically labeled multiple tumor-cell lines as effectively as hnRNP A2/B1 monoclonal antibodies. When conjugated with fluorescent carbon nanodots (CDots) it could freely enter multiple living tumor cell lines (HepG2, MCF-7, H1299, and HeLa), whose growth it inhibited by targeting hnRNP A2/B1. Similar inhibitory effects were observed when the GFP-HepG2 hepatocarcinoma cells treated with C6-8-conjugated CDots were implanted in nude mice. Our work provides a new aptamer for targeting/labeling multiple tumor cell types, and its nanoparticle conjugates bring further advantages that increase its potential for use in cancer diagnosis and therapy. (C) 2015 Elsevier Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 1 区 工程技术
小类 | 1 区 工程:生物医学 1 区 材料科学:生物材料
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 工程:生物医学 1 区 材料科学:生物材料
JCR分区:
出版当年[2013]版:
Q1 MATERIALS SCIENCE, BIOMATERIALS Q1 ENGINEERING, BIOMEDICAL
最新[2023]版:
Q1 ENGINEERING, BIOMEDICAL Q1 MATERIALS SCIENCE, BIOMATERIALS

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Beijing Inst Basic Med Sci, Beijing 100850, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [2]Acad Mil Med Sci, State Key Lab Toxicol & Med Countermeasures, Beijing 100850, Peoples R China [3]Acad Mil Med Sci, Lab Toxicant Anal, Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25477 今日访问量:0 总访问量:1499 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)